Endothelial Akt Signaling Is Rate-Limiting for Rapamycin Inhibition of Mouse Mammary Tumor Progression
Thuy L. Phung(The University of Texas at San Antonio Health Science Center), Laura E. Benjamin(BioHybrid Solutions (United States))
Cited by 53
Related Papers
Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
|Nature|2017|853
Rapamycin Inhibition of the Akt/mTOR Pathway Blocks Select Stages of VEGF-A <sup>164</sup> –Driven Angiogenesis, in Part by Blocking S6Kinase
|Arteriosclerosis Thrombosis and Vascular Biology|2009|100